associated with a statistically significant increased risk of maternal infectious outcome (33.3% versus 16.7%, p1⁄40.16). CONCLUSION: As one would expect, more severe IBD disease and IBD flares during pregnancy are… Click to show full abstract
associated with a statistically significant increased risk of maternal infectious outcome (33.3% versus 16.7%, p1⁄40.16). CONCLUSION: As one would expect, more severe IBD disease and IBD flares during pregnancy are associated with adverse pregnancy outcomes. Additionally, although there was no difference in infectious outcomes using infliximab postpartum, larger studies are needed to confirm these findings.
               
Click one of the above tabs to view related content.